Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,213
Closed -$446K 788
2025
Q4
$446K Buy
9,213
+244
+3% +$12.1K 0.02% 536
2025
Q3
$423K Buy
8,969
+271
+3% +$13.1K 0.02% 537
2025
Q2
$420K Buy
8,698
+591
+7% +$30.2K 0.02% 506
2025
Q1
$450K Sell
8,107
-56
-0.7% -$3.03K 0.02% 456
2024
Q4
$394K Buy
+8,163
New +$415K 0.02% 465
2024
Q3
Sell
-8,002
Closed -$388K 578
2024
Q2
$388K Buy
+8,002
New +$386K 0.02% 449
2024
Q1
Sell
-8,323
Closed -$414K 540
2023
Q4
$414K Buy
8,323
+128
+2% +$6.26K 0.03% 401
2023
Q3
$440K Buy
+8,195
New +$437K 0.04% 371
2023
Q2
Sell
-7,650
Closed -$416K 464
2023
Q1
$416K Buy
7,650
+917
+14% +$44.6K 0.04% 349
2022
Q4
$326K Sell
6,733
-246
-4% -$10.8K 0.03% 383
2022
Q3
$265K Buy
+6,979
New +$311K 0.02% 435

Other funds holding SNY

IFG Advisory's SNY Position: Q1 2026 in Review

IFG Advisory sold out of Sanofi (SNY) in Q1 2026, closing a stake of 9,213 shares — an estimated $446K sold.

IFG Advisory first reported a position in SNY in Q3 2022 and held it in 11 quarters. The position peaked at $450K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • IFG Advisory reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • IFG Advisory sold 9,213 Sanofi shares in Q1 2026, an estimated $446K.
  • IFG Advisory first reported a position in Sanofi in Q3 2022 and held it in 11 quarters.
  • IFG Advisory's Sanofi position peaked at $450K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.